You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

Long-term Traditional Chinese Medicine Use and Incidence of Metabolic Syndrome in Schizophrenia: A Retrospective Cohort Study

  • Xiamen City Xianyue Hospital, Xiamen, China

The final, formatted version of the article will be published soon.

Abstract

Objective: To assess the impact of medium- to long-term traditional Chinese medicine (TCM) combined with antipsychotics on metabolic syndrome (MetS) in schizophrenia patients and explore its prevalence and influencing factors. Methods: A retrospective cohort study included 897 inpatients (≥18 years, good medication adherence, hospitalized ≥6 months) with schizophrenia (2022–2024). Divided into TCM-exposed (n=163) and non-exposed (n=734) groups, MetS incidence was tracked. Univariate analysis screened confounders, followed by multivariate logistic regression to calculate odds ratios (OR). Results: MetS prevalence was 27.53% overall; 17.18% in the TCM group vs. 29.84% in the non-TCM group. TCM group had lower central obesity (29.5% vs. 39.8%) and hyperglycemia (13.50% vs. 21.8%). Multivariate analysis showed: higher education (>12 years, OR=0.45), TCM use (OR=0.50), risperidone (OR=0.54), aripiprazole (OR=0.39) were protective; quetiapine (OR=1.86), clozapine (OR=1.74), and high BMI (OR=1.39) were risk factors. Conclusion: MetS is common in schizophrenia. TCM, aripiprazole, risperidone, and higher education reduce MetS risk, while quetiapine, clozapine, and high BMI increase it. Long-term TCM may mitigate antipsychotic-induced metabolic harm, offering a feasible option for chronic patients.

Summary

Keywords

antipsychotic drugs, Metabolic syndrome (MetS), Retrospective cohort study, Schizophrenia, Traditional Chinese medicine (TCM)

Received

02 October 2025

Accepted

17 February 2026

Copyright

© 2026 Zhang, Gu, Huang and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mei Guo

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics